These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 1363118)

  • 1. Possible use of 1% Virkon solution for laboratory discard jars.
    Coates D; Spencer MB; Wareing DR; Lee L
    J Hosp Infect; 1992 Dec; 22(4):337-9. PubMed ID: 1363118
    [No Abstract]   [Full Text] [Related]  

  • 2. Smart Card Decontamination in a High-Containment Laboratory.
    Gabbert LR; Smith JD; Neilan JG; Ferman GS; Rasmussen MV
    Health Secur; 2018; 16(4):244-251. PubMed ID: 30096256
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Irritating effect and dermal toxicity of virkon, a disinfectant widely used in Poland].
    Krysiak B; Stetkiewicz J; Kieć-Swierczyńska M
    Med Pr; 2000; 51(5):457-63. PubMed ID: 11199175
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Virucidal activity of Virkon S on human enterovirus.
    Chan YF; Abu Bakar S
    Med J Malaysia; 2005 Jun; 60(2):246-8. PubMed ID: 16114171
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Re: Antimycobacterial activity of 'Virkon'.
    Auchincloss TR
    J Hosp Infect; 1993 Dec; 25(4):301-4. PubMed ID: 7907629
    [No Abstract]   [Full Text] [Related]  

  • 6. Inactivation of adenovirus types 5 and 6 by Virkon S.
    McCormick L; Maheshwari G
    Antiviral Res; 2004 Oct; 64(1):27-33. PubMed ID: 15451176
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of fungicidal efficacy of benzalkonium chloride (Steramina G u.v.) and Virkon-S against Microsporum canis for environmental disinfection.
    Marchetti V; Mancianti F; Cardini G; Luchetti E
    Vet Res Commun; 2006 Apr; 30(3):255-61. PubMed ID: 16437301
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Sporicidal activity of VIRKON].
    Delia S
    Ann Ig; 1995; 7(1):43-7. PubMed ID: 8663964
    [No Abstract]   [Full Text] [Related]  

  • 9. [Evaluation of the bactericidal activity of a new disinfectant (Virkon)].
    Clerici P; Decé F; Pescatori T; Pagani N
    Ann Ig; 1992; 4(2):113-7. PubMed ID: 1283942
    [No Abstract]   [Full Text] [Related]  

  • 10. [Study on inactivation of waste solutions of VIRKON].
    Manna F; Bolasco A; Lucarini C
    Ann Ig; 1995; 7(1):13-8. PubMed ID: 8663959
    [No Abstract]   [Full Text] [Related]  

  • 11. [Evaluation of allergic sensitivity to the virkon disinfectant preparation widely used in Poland].
    Krysiak B; Stetkiewicz J; Kieć-Swierczyńska M
    Med Pr; 2000; 51(6):603-8. PubMed ID: 11288688
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tuberculocidal activity of a peroxymonosulphate-based disinfectant-detergent (Virkon).
    De Lorenzi S; Finzi G; Mosca B; Salvatorelli G
    J Hosp Infect; 2008 Jan; 68(1):96-7. PubMed ID: 18069085
    [No Abstract]   [Full Text] [Related]  

  • 13. [Evaluation of the disinfectant activity of the compound VIRKON].
    Ricci A; Carnuccio V; Suzzi R; Pascali A; Gasponi A; Bolognesi V; Bolognesi E
    Ann Ig; 1995; 7(1):27-33. PubMed ID: 8663961
    [No Abstract]   [Full Text] [Related]  

  • 14. [Evaluation of mycobactericidal activity of the disinfectant VIRKON by polymerase chain reaction (PCR)].
    Vollaro L; Scioli C
    Ann Ig; 1995; 7(1):49-53. PubMed ID: 8663965
    [No Abstract]   [Full Text] [Related]  

  • 15. [Chemical characteristics and mechanisms of action of VIRKON].
    Manna F; Bolasco A; Lucarini C
    Ann Ig; 1995; 7(1):5-11. PubMed ID: 8663966
    [No Abstract]   [Full Text] [Related]  

  • 16. [Evaluation of the antiviral activity of the disinfectant VIRKON].
    Bonfanti C; Pollara P; De Rango C; Turano A
    Ann Ig; 1995; 7(1):55-62. PubMed ID: 8663967
    [No Abstract]   [Full Text] [Related]  

  • 17. The effect of Virkon S fogging on survival of Salmonella enterica and Staphylococcus aureus on surfaces in a veterinary teaching hospital.
    Dunowska M; Morley PS; Hyatt DR
    Vet Microbiol; 2005 Feb; 105(3-4):281-9. PubMed ID: 15708826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Evaluation of the efficacy of a peroxide system (VIRKON) with special reference to in vitro kinetics of disinfection].
    Gasparini R
    Ann Ig; 1995; 7(1):19-25. PubMed ID: 8663960
    [No Abstract]   [Full Text] [Related]  

  • 19. In vitro study of disinfectants on the embryonation and survival of Toxascaris leonina eggs.
    El-Dakhly KM; Aboshinaf ASM; Arafa WM; Mahrous LN; El-Nahass E; Gharib AF; Holman PJ; Craig TM
    J Helminthol; 2018 Sep; 92(5):530-534. PubMed ID: 28974272
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of in-vitro efficacy of 1% Virkon against bacteria, fungi, viruses and spores by means of AFNOR guidelines.
    Herńndez A; Martró E; Matas L; Martín M; Ausina V
    J Hosp Infect; 2000 Nov; 46(3):203-9. PubMed ID: 11073729
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.